Well Told Grants

Federal grant recipients / New York

Federal grants to Lucerna Inc

Brooklyn, New York · Small businesses · UEI J3MWGA6WFCG3

Lucerna Inc in Brooklyn, New York received $2.7 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Aging Research, with $2.1 million. In fiscal 2025 it was awarded $313,148.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to Lucerna Inc by fiscal year
Fiscal yearAwardsAmount
FY 20210$0
FY 20221$845,353
FY 20231$874,414
FY 20242$692,116
FY 20251$313,148

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Lucerna Inc

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Aging Research 93.8662$2.1 million
Arthritis, Musculoskeletal and Skin Diseases Research 93.8461$313,148
Allergy and Infectious Diseases Research 93.8551$300,000

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services4$2.7 million

Largest awards

The 4 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
Fluorescent ire sensor for synucleinopathy drug discovery - abstract the goal of this phase II proposal is to advance synucleinopathy disease drug discovery by validating a high- throughput screening (HTS)-ready assay and establish a rna structure sensor platform for rna-targeted drug discovery. Dem
ASST_NON_R44NS130946_075 on USAspending
Aging ResearchSeptember 21, 2022$1.7 million
Cell-based rna degradation assay for C9ALS/ftd drug discovery - project summary to overcome the “undruggable” protein problem, researchers have turn to drugging mrnas that translate into these undruggable proteins or non-coding rnas that regulate the biogenesis of these proteins. Avenues of controll
ASST_NON_R43AG085837_075 on USAspending
Aging ResearchNovember 17, 2023$392,116
In vivo imaging platform for DM1 drug discovery - project abstract/summary myotonic dystrophy type 1 (DM1) is a multisystemic disorder caused by cug repeat expansion in the 3’ utr of the dmpk gene. DM1 patients can have between 50 to 5,000 cug repeats, leading to dmpk mrna aggregation within the nuc
ASST_NON_R43AR086092_075 on USAspending
Arthritis, Musculoskeletal and Skin Diseases ResearchJuly 29, 2025$313,148
Targeted rna degradation assay for new antiviral drug discovery - project summary there are currently no effective vaccines or antiviral drugs for most of the viral diseases afflicting human. Development of new therapy is challenging and expensive, and often complicated by drug resistance. It is now
ASST_NON_R43AI186768_075 on USAspending
Allergy and Infectious Diseases ResearchJuly 29, 2024$300,000

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Lucerna Inc get?

$2.7 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Lucerna Inc the most?

The Department of Health and Human Services, with $2.7 million in 4 awards.

What is Lucerna Inc's largest federal grant?

$1.7 million under Aging Research, with its first action in the period on September 21, 2022. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Lucerna Inc?

Its largest are Aging Research, Arthritis, Musculoskeletal and Skin Diseases Research and Allergy and Infectious Diseases Research.

Other grant recipients in Brooklyn

Largest federal grant recipients in New York · Federal grants in New York